Tenders Are Invited For Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredients/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure

Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredients/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure. The Subject Of This Publication Is The Conclusion Of Agreements In Accordance With Section 130A (8) Sgb V To Various Active Ingredients/Active Ingredient Combinations As Part Of A So-Called Open House Procedure. Under The Specification Of Uniform Contractual Conditions And Uniform Access Procedures, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Is Offered The Conclusion Or Accession To A Discount Contract In Accordance With Section 130A (8) Sgb V For The Active Ingredient/Active Ingredient Combination. Interested Pharmaceutical Companies Can Download The Order Documents (Participation Documents And Contract) At: Https://Www.Dtvp.De/Satellite/Notice/Cxp4y6m5qtw, After Registration. The E-Mail Address Named In The Client For The Purpose Of The Unrestricted And Complete Fee-Free Access Of The Order Documents Has No Existence. Information Can Be Obtained Exclusively, Via Your Registration, On The Awarding Platform Dtvp, Under The Communication Rider. Information And Answers About Other Places Are Not Binding. The Prerequisite For The Conclusion Of A Contract Is That The Interested Pharmaceutical Company Fully Completed And Signed The Required Procedural Documents. Every Pharmaceutical Company That Meets The Participation Requirements And Documents This By Signing The Declarations And The Discount Contract Can Join The Discount Contract. New: The Possibility Of Qualified Electronic Signature Via Fp Sign Is Now Also Offered. For More Information, Please Refer To The Process Information Form. There Is No Exclusivity. The Accession Or Conclusion Of The Contract Can Take Place At Any Time And On The Same Conditions. Individual Contract Negotiations Are Not Carried Out. The Start Of The Contract Can Only Be One Month. The Earliest Start Of The Contract Is 01.10.2025. Based On This, The Contract Term Is A Maximum Of 22 Months. The Contract Ends At The Latest On July 31, 2027, Regardless Of The Date Of The Conclusion Of The Contract. The Offer Must Be Available At The Start Of The Contract On October 1St, 2025 By 26.08.2025 At The Latest; However, No Contracts On The Part Of The Aok Nordost Are Concluded Before 08.09.2025. For A Later Start Of The Contract, The Offer Of The Offers Of The 5Th Of The Previous Month Is The Submission Period. (Example: Start Of The Contract 01.11.2025; Deadline For Submitting The Offer: 05.10.2025). If The Aok Nordost Gives An Exclusive Surcharge For The Active Ingredient/Combination Of Active Ingredients During The Contract Term, The Contractual Regulations Concluded As Part Of This Publication Apply. The Present Publication Is Not The Allocation Of A Public Mandate Within The Meaning Of The Award Coordination Directive 2014/24/Eu Of The European Parliament And The Council Or The Public Property. Around